# Commercial Bancgroup, Inc.: financial statements, quarterly

CBK · Nasdaq · CIK 1981546 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbk.md) · [Financials](/companies/cbk/financials.md) · [Filings](/companies/cbk/filings.md) · [Insiders](/companies/cbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbk/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $m | [1.8](/filings/0001213900-25-110914.md) | [3.2 d](/filings/0001213900-26-033659.md) | [2.5](/filings/0001213900-26-055885.md) | [2.7](/filings/0001213900-26-088408.md) | [2.8](/filings/0001213900-25-110914.md) | [2.2 d](/filings/0001213900-26-033659.md) | [2.3](/filings/0001213900-26-055885.md) | [2.7](/filings/0001213900-26-088408.md) |
| Net income | $m | [9.2](/filings/0001213900-25-110914.md) | [5.6 d](/filings/0001213900-26-033659.md) | [8.7](/filings/0001213900-26-055885.md) | [8.9](/filings/0001213900-26-088408.md) | [9.5](/filings/0001213900-25-110914.md) | [10.1 d](/filings/0001213900-26-033659.md) | [9.5](/filings/0001213900-26-055885.md) | [10.2](/filings/0001213900-26-088408.md) |
| Diluted EPS | $ per share | [0.74](/filings/0001213900-25-110914.md) | not reported | [0.72](/filings/0001213900-26-055885.md) | [0.73](/filings/0001213900-26-088408.md) | [0.77](/filings/0001213900-25-110914.md) | not reported | [0.70](/filings/0001213900-26-055885.md) | [0.74](/filings/0001213900-26-088408.md) |
| Basic EPS | $ per share | [0.75](/filings/0001213900-25-110914.md) | not reported | [0.72](/filings/0001213900-26-055885.md) | [0.73](/filings/0001213900-26-088408.md) | [0.77](/filings/0001213900-25-110914.md) | not reported | [0.70](/filings/0001213900-26-055885.md) | [0.75](/filings/0001213900-26-088408.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [178](/filings/0001213900-26-033659.md) | not reported | not reported | [155](/filings/0001213900-25-110914.md) | [144](/filings/0001213900-26-088408.md) | [168](/filings/0001213900-26-055885.md) | [170](/filings/0001213900-26-088408.md) |
| Total assets | $m | not reported | not reported | not reported | [2,301](/filings/0001213900-26-033659.md) | not reported | not reported | [2,214](/filings/0001213900-25-110914.md) | [2,291](/filings/0001213900-26-088408.md) | [2,329](/filings/0001213900-26-055885.md) | [2,377](/filings/0001213900-26-088408.md) |
| Total liabilities | $m | not reported | not reported | not reported | [2,081](/filings/0001213900-26-033659.md) | not reported | not reported | [1,969](/filings/0001213900-25-110914.md) | [2,006](/filings/0001213900-26-088408.md) | [2,035](/filings/0001213900-26-055885.md) | [2,074](/filings/0001213900-26-088408.md) |
| Long-term debt | $m | not reported | not reported | not reported | [106](/filings/0001213900-26-033659.md) | not reported | not reported | [100](/filings/0001213900-25-110914.md) | [78.6](/filings/0001213900-26-088408.md) | [73.2](/filings/0001213900-26-055885.md) | [73.2](/filings/0001213900-26-088408.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [3.4](/filings/0001213900-26-033659.md) | not reported | not reported | [62.7](/filings/0001213900-25-110914.md) | [88.3](/filings/0001213900-26-088408.md) | [45.1](/filings/0001213900-26-055885.md) | [103](/filings/0001213900-26-088408.md) |
| Shareholders' equity | $m | [196](/filings/0001213900-26-033659.md) | [211](/filings/0001213900-25-110914.md) | [215](/filings/0001213900-25-110914.md) | [220](/filings/0001213900-26-088408.md) | [226](/filings/0001213900-26-088408.md) | [235](/filings/0001213900-26-088408.md) | [245](/filings/0001213900-25-110914.md) | [285](/filings/0001213900-26-088408.md) | [294](/filings/0001213900-26-088408.md) | [303](/filings/0001213900-26-088408.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.2 d](/filings/0001213900-26-033659.md) | [12.1](/filings/0001213900-26-055885.md) | [7.5 d](/filings/0001213900-26-088408.md) | [8.4 d](/filings/0001213900-25-110914.md) | [9.1 d](/filings/0001213900-26-033659.md) | [13.4](/filings/0001213900-26-055885.md) | [10.1 d](/filings/0001213900-26-088408.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001213900-26-033659.md) | [0.3](/filings/0001213900-26-055885.md) | [0.7 d](/filings/0001213900-26-088408.md) | [0.5 d](/filings/0001213900-25-110914.md) | [0.3 d](/filings/0001213900-26-033659.md) | [0.2](/filings/0001213900-26-055885.md) | [1.3 d](/filings/0001213900-26-088408.md) |
| Dividends paid | $m | [0.0 d](/filings/0001213900-26-033659.md) | [2.0](/filings/0001213900-26-055885.md) | [0.0 d](/filings/0001213900-26-088408.md) | [0.0 d](/filings/0001213900-25-110914.md) | [0.0 d](/filings/0001213900-26-033659.md) | [1.4](/filings/0001213900-26-055885.md) | [1.4 d](/filings/0001213900-26-088408.md) |
| Share repurchases | $m | [1.8 d](/filings/0001213900-26-033659.md) | [1.0](/filings/0001213900-26-055885.md) | [0.0 d](/filings/0001213900-26-088408.md) | [0.0 d](/filings/0001213900-25-110914.md) | [0.0 d](/filings/0001213900-26-033659.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.2](/filings/0001213900-25-110914.md) | [12.1](/filings/0001213900-26-055885.md) | [12.2](/filings/0001213900-26-088408.md) | [12.2](/filings/0001213900-25-110914.md) | [13.7](/filings/0001213900-26-055885.md) | [13.7](/filings/0001213900-26-088408.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,701,270 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001213900-26-088408.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.